This analysis revealed a significant variation in pathway activity (Fig. 5C), demonstrating enhanced enrichment of the mitotic spindle and TGF-β signaling pathways in the high-score group, indicating their potential involvement in PAAD progression. The gene discussed is TGFB1; the disease is pancreatic adenocarcinoma.